Escherichia coli DNA Helicase II Is Active as a Monomer by Mechanic, Leah E. et al.
Escherichia coli DNA Helicase II Is Active as a Monomer*
(Received for publication, December 16, 1998)
Leah E. Mechanic‡§¶, Mark C. Hall¶i, and Steven W. Matsoni**
From the ‡Department of Biochemistry and Biophysics, §Protein Engineering and Molecular Genetics Training Program,
iDepartment of Biology, and **Curriculum in Genetics and Molecular Biology, University of North Carolina,
Chapel Hill, North Carolina 27599
Helicases are thought to function as oligomers (gener-
ally dimers or hexamers). Here we demonstrate that
although Escherichia coli DNA helicase II (UvrD) is ca-
pable of dimerization as evidenced by a positive inter-
action in the yeast two-hybrid system, gel filtration
chromatography, and equilibrium sedimentation ultra-
centrifugation (Kd 5 3.4 mM), the protein is active in vivo
and in vitro as a monomer. A mutant lacking the C-
terminal 40 amino acids (UvrDD40C) failed to dimerize
and yet was as active as the wild-type protein in ATP
hydrolysis and helicase assays. In addition, the
uvrDD40C allele fully complemented the loss of helicase
II in both methyl-directed mismatch repair and excision
repair of pyrimidine dimers. Biochemical inhibition ex-
periments using wild-type UvrD and inactive UvrD
point mutants provided further evidence for a func-
tional monomer. This investigation provides the first
direct demonstration of an active monomeric helicase,
and a model for DNA unwinding by a monomer is
presented.
The first DNA helicase was identified and characterized
more than 20 years ago (1, 2). Since then, the biochemical
properties and biological functions of many helicases have been
firmly established (3–5), and new helicases are continually
being discovered and characterized from prokaryotic, eukary-
otic, and viral systems. Despite the great attention helicases
have received in recent years due to their fundamental impor-
tance in DNA and RNA metabolism, many details of the mech-
anism(s) by which helicases couple the energy derived from
nucleoside 59-triphosphate hydrolysis to the separation of the
two strands of duplex nucleic acids are still not known.
Several models for helicase-catalyzed unwinding have been
proposed (reviewed in Ref. 5). A common feature of these mod-
els is the existence of multiple DNA- or RNA-binding sites
within the active enzyme. Multiple binding sites are believed to
be essential for processive translocation of the helicase along
the nucleic acid. This requirement is thought to be satisfied by
an oligomeric enzyme, and in general, helicases have been
divided into two oligomeric categories: dimers and hexamers.
Whereas the assembly state of several hexameric helicases has
been described in detail (6–12), information on dimeric heli-
cases has been mostly limited to studies of the E. coli Rep
enzyme.
Lohman and colleagues (13–15), using a combination of
steady-state and pre-steady-state kinetic studies, have demon-
strated that DNA binding induces dimerization of E. coli Rep
helicase and that dimers are the active form of the enzyme. A
model for processive DNA unwinding catalyzed by the Rep
helicase has been proposed in which the two subunits of the
active dimeric enzyme alternate binding to the double-stranded
DNA (dsDNA)1 region at an unwinding fork to catalyze ATP
hydrolysis-dependent strand separation (15). In this rolling
model, cycling of the two subunits through a duplex region
during processive unwinding is driven by changes in single-
stranded (ssDNA) and dsDNA binding affinities. These
changes in affinity are allosterically regulated by the state of
nucleotide binding of each subunit (recently reviewed in Ref. 5).
DNA helicase II (UvrD), which shares approximately 40%
amino acid sequence identity with Rep, performs a variety of
functions in E. coli including essential roles in methyl-directed
mismatch repair (16) and nucleotide excision repair (17, 18). In
a previous report, UvrD was shown to form dimers and higher
order oligomers in solution, and dimerization was stimulated in
the presence of ssDNA (19). It has been proposed that UvrD
functions as a dimer and may employ an unwinding mecha-
nism similar to that proposed for Rep (5, 20). This suggestion is
based on (i) the extensive sequence similarity between Rep and
UvrD, (ii) the abundance of data suggesting dimerization is
required for activity of the E. coli Rep helicase, (iii) the obser-
vation that UvrD forms dimers and higher order oligomers in
solution, and (iv) current models for helicase-catalyzed DNA
unwinding mechanisms in which the requirement for multiple
DNA-binding sites is generally satisfied by multiple subunits
in an active enzyme. However, there is currently no direct
evidence to indicate that UvrD is functional as a dimer or to
favor a rolling model for UvrD-catalyzed unwinding.
During the course of a yeast two-hybrid screen of an E. coli
genomic library using the uvrD gene as bait, we found that
UvrD interacts with itself in support of the notion of dimeriza-
tion. However, a UvrD mutant was constructed that failed to
dimerize yet functioned in two DNA repair pathways in vivo
and was active as a ssDNA-stimulated ATPase and a helicase
in vitro. This result prompted a thorough biophysical and bio-
chemical analysis of the oligomeric state of UvrD. We conclude
that UvrD is active as a monomer, and unwinding mechanisms
based on a monomeric helicase are discussed.
EXPERIMENTAL PROCEDURES
Materials
Bacterial Strains and Plasmids—E. coli BL21(DE3) (F2 ompT [lon]
hsdSBrB-mB- gal dcm lDE3) was from Novagen, Inc. BL21(DE3)DuvrD
and JH137DuvrD were constructed previously in this laboratory (21).
JH137 (K91 din D1:: MudI (Aprlac)) was obtained from P. Model.
Plasmids pET-9d, pET-11d, and pLysS were from Novagen, Inc.
M13mp7 ssDNA was prepared as described (22). Construction of plas-
mids that express UvrD and the various UvrD mutants have been
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described previously (21, 23, 24). To construct a plasmid that expressed
UvrDD40C, pET11d-UvrD was digested to completion with BsiW1. The
59 extension was filled in using DNA polymerase I (large fragment) and
dNTPs, and the plasmid was ligated with T4 DNA ligase. This caused
a 11 frameshift at codon 676, changing 59-GTACGCCACGCTA-
AGTTT-39 (Val-Arg-His-Ala-Lys-Phe) to 59-GTACGTACGCCACGCTA-
A-39 (Val-Arg-Thr-Pro-Arg-TER). The uvrDD40C mutation was
confirmed by DNA sequencing using the Sequenase kit (U. S. Bioc-
hemical Corp.).
Oligonucleotides, Nucleotides, and Proteins—Oligonucleotide (dT)16
was from The Midland Certified Reagent Co. The 2-aminopurine (2-
AP)-substituted oligonucleotides were synthesized by Genosys. All nu-
cleotides were from Amersham Pharmacia Biotech. All enzymes used
for cloning and PCR were from New England Biolabs, with the excep-
tion of T4 DNA ligase, which was from Roche Molecular Biochemicals.
Thyroglobulin, catalase, rabbit muscle aldolase, and cytochrome c were
from Sigma. Human transferrin was from Calbiochem.
Protein Purification—UvrD and UvrDD40C were overexpressed
prior to purification by growing either a 10-liter culture of BL21(DE3)/
pLysS cells containing pET11d-UvrD (21) or BL21(DE3)DuvrD/pLysS
cells containing pET11d-UvrDD40C to an optical density (600 nm) of 1.0
at 37 °C. Protein expression was induced by adding 0.4 mM isopropyl-
b-D-thiogalactopyranoside, and growth was continued for an additional
4 h. Purification of wild-type helicase II was performed according to a
previously published procedure (19). UvrDD40C was purified using the
same procedure with one modification. UvrDD40C was loaded onto an
ssDNA-cellulose column (5.8 mg ssDNA/g of cellulose) at 0.1 M NaCl in
Buffer A (20 mM Tris-HCl (pH 8.3 at 25 °C), 20% glycerol (v/v), 1 mM
EDTA, 0.5 mM EGTA, and 15 mM 2-mercaptoethanol) instead of Buffer
A 1 0.2 M NaCl. The column was washed using Buffer A 1 0.2 M NaCl
and eluted using Buffer A 1 1 M NaCl.
Methods
Yeast Two-hybrid System—Plasmids and strains for the yeast two-
hybrid system were from CLONTECH. An E. coli genomic library was
constructed previously in pGAD424 (25). The library was screened for
UvrD-interacting proteins as described (25). The bait plasmid was
pGBT9-UvrD. Vent DNA polymerase was used to amplify the uvrD
gene by PCR using pET9d-UvrD as target. Amplified uvrD was cloned
into the SmaI site of pGAD424 and pGBT9 to create in-frame transla-
tional fusions with the GAL4 transcriptional activation domain and
DNA binding domain, respectively. These constructs were designated
pGAD424-UvrD and pGBT9-UvrD.
Deletions from the N and C termini of UvrD were generated using
convenient restriction enzyme sites within the uvrD gene. The restric-
tion enzymes XmnI, AvaII, and BstBI were used to generate the N-
terminal deletions uvrDD276N, uvrDD309N, and uvrDD383N, respec-
tively. The uvrD PCR product described in the preceding paragraph was
digested individually with each of these enzymes, and the appropriate
fragment was purified and ligated into the SmaI site of pGAD424 to
generate a fusion with the GAL4 activation domain. Blunt ends were
generated by a DNA polymerase I (large fragment)-catalyzed fill-in
reaction where necessary. All clones produced in-frame translational
fusions and were confirmed by sequence analysis. pGAD424-UvrDD40C
was generated by digestion of pGAD424-UvrD with BsiWI and BglII,
gel purification, fill-in of the 59-overhanging ends with DNA polymerase
I (large fragment), and re-ligation of the blunt ends.
Two-hybrid interactions were characterized using the lacZ reporter
gene in strain SFY526 or the HIS3 reporter gene in strain HF7c. In
HF7c, interactions were identified by growth on media lacking histi-
dine. Assays for b-galactosidase activity encoded by the lacZ gene in
SFY526 were performed using the substrate o-nitrophenyl b-D-galacto-
pyranoside as described by the supplier (CLONTECH), and quantified
as Miller units (26).
Analytical Ultracentrifugation—Sedimentation equilibrium and sed-
imentation velocity experiments were done using a Beckman XL-A
centrifuge and an An-60ti rotor at 20 °C. Protein was prepared for these
experiments by extensive dialysis into the appropriate buffer. For sed-
imentation equilibrium experiments the buffer contained 20 mM Tris-
HCl (pH 8.3 at 25 °C), 0.2 M NaCl, 20% glycerol (v/v), 1 mM EDTA, 1 mM
EGTA, and 15 mM 2-mercaptoethanol. For velocity sedimentation ex-
periments the buffer contained 25 mM Tris-HCl (pH 7.5 at 25 °C), 50 mM
NaCl, 3 mM MgCl2, 20% glycerol (v/v), and 5 mM 2-mercaptoethanol.
Solvent densities (r) were measured using a Mettler DA-110 M density
meter. The partial specific volume for UvrD and UvrDD40C was calcu-
lated to be n 5 0.729 at 20 °C using SEDNTERP (27).
Equilibrium ultracentrifugation experiments were performed in
6-channel (1.2 cm path) charcoal-epon centrifuge cells (Beckman). The
equilibrium experiment was performed using three different concentra-
tions of UvrD (1.1, 2.1, and 3.8 mM) and UvrDD40C (2.8, 5.0, and 8.4
mM). Protein concentrations were determined from absorbances col-
lected during the low speed scans in the ultracentrifuge. Scans at 280
nm were recorded every 2 h. After 30 h the cell was judged to be at
equilibrium. This was confirmed by subtracting successive plots and
examining residuals for the absence of any systematic patterns. For
UvrD the speeds used were 5,000, 7,500, and 10,000 rpm, and for
UvrDD40C the speeds were 7,200, 8,600, and 12,600 rpm. All concen-
trations of UvrDD40C reached equilibrium within the 30-h period for
each speed. Three of the data sets obtained with the wild-type protein
did not reach equilibrium during the course of the experiment (1.1 mM
at 5,000 rpm, 2.1 mM at 5,000 rpm, and 3.8 mM at 10,000 rpm) and were
not considered in the analysis.
Several models were fit to data from equilibrium centrifugation
experiments using NONLIN (28). Separate concentrations and differ-
ent speeds were analyzed individually, in groups, and globally. The
models primarily considered were single ideal species and ideal mono-
mer 7 dimer equilibrium. In addition, other models were examined
including non-ideality, monomer 7 trimer and monomer 7 tetramer.
Molecular masses were calculated based on the values for s (reduced





M is the molecular weight; R is the gas constant; T is the temperature
in degrees Kelvin; n is the partial specific volume (ml/g) of the protein;
v is the angular velocity of the rotor (radians/s), and r is the measured
density of the buffer (g/ml). Kd values were calculated using Equation 2
for the model of monomer 7 dimer equilibrium (see Equation 3).
C~r! 5 d 1 C1,0e~s1j! 1 C1,02e~ln K212s1j! (Eq. 2)
j 5 ~r2 2 r02!/2 (Eq. 3)
C(r) is the total protein concentration (mg/ml) at the radius (r); d is the
base-line offset used to compensate for absorbance measurements of 0
not being precisely equal to 0 protein concentration; C1,0 is the monomer
concentration at the reference distance (r0); and K2 is the association
constant for monomer 7 dimer model (28, 29). The reference distance,
or reference radial position, is chosen in data analysis and is usually
near the meniscus in the cell. s1 is the reduced molecular weight for the
monomer.
Velocity experiments were performed with 350-ml samples in two-
channel charcoal epon centerpieces (1.2 cm path) (Beckman). The rotor
speed was 50,000 rpm. Initial protein concentrations were approxi-
mately 7.5 mM. Experimental samples analyzed in the presence of
nucleotide contained 0.2 mM AMP-PNP. For reactions containing
ssDNA, the DNA molecule used was a (dT)16 oligonucleotide containing
the modified base 2-aminopurine (AP). The two ssDNA substrates were
either 59-TTTTT(AP)TTTT(AP)TTTTT-39 or 59-TTT(AP)TT(AP)TT(AP)
TT(AP)TTT-39. The molar ratio of protein to DNA was 1:1.25. Data
obtained from sedimentation velocity experiments in the absence of
DNA (protein alone or protein with nucleotide) were collected at either
285 or 290 nm. In the presence of DNA, sedimentation was monitored
at 315 nm to detect only the modified (dT)16 molecule. Scans were
recorded at 1-min intervals in a continuous mode.
Sedimentation velocity data were analyzed using the program Sved-
berg (30). Sedimentation coefficients (s*) were determined by fitting the
modified Fujita-MacCoshman equation for a single species and two
species to the data (31). For experiments containing DNA, the program
dCdT (32) was used to obtain sw values for interacting species. The sw
values obtained using dCdT were consistent with s* values obtained
using Svedberg. A control sedimentation velocity experiment performed
using the 2-AP oligonucleotide in the absence of protein confirmed the
identity of the two species in the experiment containing DNA (DNA
alone and DNA-protein complex). The values s* and sw were corrected
for solvent density and viscosity and normalized to standard conditions
to produce the s20,w value (33, 34). Values for n were corrected for
percentage glycerol as described (35, 36).
Gel Filtration—The apparent molecular mass of UvrD and UvrD
mutants was determined in the presence and absence of ligands using
a Superose 12 HR 10/30 column (Amersham Pharmacia Biotech) and
high pressure liquid chromatography system (Rainin, model HPXL) at
4 °C. Column buffer was 25 mM Tris-HCl (pH 7.5), 100 mM NaCl, 3 mM
MgCl2, 5 mM 2-mercaptoethanol, and 20% glycerol. When present in the
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column buffer, ATP was 0.5 mM. Proteins (25 mg) were injected onto the
column in a volume of 50 ml at a flow rate of 0.2 ml/min. When present,
32P-labeled oligonucleotide (dT)16 was included in the loaded sample at
a concentration of 11.2 mM. Samples were passed through the column at
a flow rate of 0.2 ml/min, and elution of protein peaks was monitored
continuously by absorbance at 280 nm. The elution of (dT)16 was fol-
lowed by scintillation counting of column fractions. Samples were sub-
jected to centrifugation prior to loading to remove particulate matter
and any insoluble protein. Comparison of protein concentration meas-
urements made before and after application to the column revealed that
essentially all protein was soluble and recovered in a single peak. A
standard curve of log molecular mass versus retention time was gener-
ated in the absence of ATP using the following proteins under the
column buffer conditions described above: thyroglobulin (668,000 Da),
catalase (212,000 Da), rabbit muscle aldolase (158,000 Da), human
transferrin (80,000 Da), and cytochrome c (12,400 Da). The retention
time of all protein standards was not significantly altered by the pres-
ence of ATP.
Genetic Assays—Genetic complementation assays were performed
using JH137 and derivatives. UV irradiation survival assays (23) and
determination of spontaneous mutation frequencies (37) were per-
formed as described previously.
ATPase Assays—The standard ATPase reaction mixture contained
25 mM Tris-HCl (pH 7.5), 3 mM MgCl2, 20 mM NaCl, and 5 mM 2-mer-
captoethanol. The reaction stop solution was 33 mM EDTA, 7 mM ATP,
and 7 mM ADP. In general, reactions were executed and products
separated by thin layer chromatography as described previously (38).
All reactions were incubated at 37 °C. When [3H]ATP was used, the
results were quantified using a liquid scintillation counter. When
[a-32P]ATP was used, the results were quantified using a Storm 840
PhosphorImager and ImageQuant software (Molecular Dynamics).
Background signals measured in the absence of enzyme were typically
between 1 and 2% and were subtracted from the experimental data.
For inhibition assays the concentration of UvrD was 4 nM and the
concentrations of UvrD-K35M, UvrD-E221Q, and UvrD-R605A were
125 nM. Reaction mixtures (30 ml) contained 1 mM [a-32P]ATP and 1.8
mM oligonucleotide (dT)16 (molecules). Wild-type and mutant helicase II
enzymes were mixed together at 15 times their final concentrations and
preincubated on ice for 10 min. Reactions were initiated by adding
enzyme (wild-type, mutant, or a mixture of both) to reaction mixtures at
37 °C. Samples (5 ml) were removed at 1-min intervals (within the
linear range of the reaction) and quenched with 5 ml of stop solution.
Reactions for examining the protein concentration dependence of the
UvrD-catalyzed ATPase reaction were identical to those for the inhibi-
tion assays except that the UvrD concentration was varied from 1 to 64
nM, and bovine serum albumin was included at 50 mg/ml. As the UvrD
concentration was decreased, samples were removed at increasing time
intervals to ensure production of a detectable signal. All data points fell
within the linear range of the reaction.
To compare the kcat values of UvrD and UvrDD40C, reaction mix-
tures (30 ml) contained 0.8 mM [3H]ATP and 30 mM M13mp7 ssDNA
(nucleotide phosphate). Reactions were initiated with enzyme at a final
concentration of 2 nM. Samples (8 ml) were removed and quenched with
8 ml of stop solution at 2-min intervals. To compare Km values of UvrD
and UvrDD40C, reaction mixtures (20 ml) contained 2 nM enzyme, 30 mM
M13mp7 ssDNA (nucleotide phosphate), and increasing concentrations
(25–500 mM) of [a-32P]ATP. Reactions were initiated with [a-32P]ATP
and incubated for 10 min. Duplicate samples of 5 ml were removed and
quenched with 5 ml of stop solution.
Helicase Assays—Helicase reaction mixtures (20 ml) contained 25 mM
Tris-HCl (pH 7.5), 3 mM MgCl2, 20 mM NaCl, 5 mM 2-mercaptoethanol,
and 3 mM ATP. For inhibition experiments, the reaction mixtures also
included 0.5 mM 20-mer oligonucleotide molecules and 5 nM 20-bp par-
tial duplex [32P]DNA substrate molecules. The partial duplex substrate
was prepared as described previously (23). The unlabeled 20-mer was
the same sequence as the 32P-labeled 20-mer used to make the partial
duplex substrate and was included at molar excess to prevent reanneal-
ing of unwound 32P-labeled 20-mer. The concentration of UvrD was 1
nM, and the concentrations of UvrD-K35M, UvrD-E221Q, and UvrD-
R605A were 3 nM. Wild-type and mutant helicase II enzymes were
mixed together at 10 times their final concentrations and incubated on
ice for 10 min. Subsequently, enzymes were incubated on ice with the
partial duplex DNA substrate in the reaction buffer for 5 min prior to
initiation of the reactions. Reactions were initiated by adding ATP and
unlabeled 20-mer at 37 °C. After incubation at 37 °C for 3 min, reac-
tions were quenched with 10 ml of stop solution (37.5% glycerol, 50 mM
EDTA, 0.05% each of xylene cyanol and bromphenol blue, and 0.3%
SDS).
For the biochemical comparison of UvrD- and UvrDD40C-catalyzed
unwinding reactions, the standard reaction mixtures included approx-
imately 0.2 nM 92-bp partial duplex [32P]DNA substrate molecules
prepared as described previously (23). Reactions were initiated with the
indicated concentration of enzyme at 37 °C, incubated for 10 min, and
quenched with 10 ml of stop solution. All reaction products were re-
solved on 8% non-denaturing polyacrylamide gels (20:1 cross-linking
ratio), and the results were visualized and quantified using a Storm 840
PhosphorImager and ImageQuant software (Molecular Dynamics).
RESULTS
UvrD Interacts with Itself in the Yeast Two-hybrid System—The
formation of dimers and higher order oligomers by UvrD has been
suggested based on gel filtration techniques and glutaraldehyde
cross-linking (19). This observation is consistent with the idea that
the active form of UvrD may be dimeric, as has been demonstrated
for Rep helicase (13–15). We discovered independent evidence for
UvrD dimerization that enabled us to begin to identify the do-
main(s) responsible for this phenomenon.
In a yeast two-hybrid screen to identify proteins that interact
with UvrD, an interacting clone was isolated that was identical
to a portion of the uvrD gene. This interacting clone encoded a
region of UvrD lacking the N-terminal 244 amino acids, sug-
gesting that the N terminus of helicase II was not essential for
oligomerization. Subsequently, an interaction between two
full-length UvrD proteins was demonstrated (Fig. 1A). To de-
fine further the interaction domain, various deletion mutants
were constructed and analyzed for their ability to interact with
wild-type UvrD in the yeast two-hybrid system using assays for
b-galactosidase activity to quantify interaction-dependent ex-
pression of a lacZ reporter gene (Fig. 1B). The results indicated
that the C-terminal half of UvrD was sufficient to produce a
detectable interaction. Removal of 383 amino acids from the N
terminus or 40 amino acids from the C terminus abolished the
two-hybrid interaction. The latter result was particularly in-
teresting because the UvrDD40C mutant had been partially
characterized previously and found to be indistinguishable
from wild-type UvrD.2 The two-hybrid data suggest that
UvrDD40C has a defect in oligomerization, which prompted a
careful examination of this property using both UvrD and
UvrDD40C. The existence of a mutant that fails to dimerize,
yet has wild-type biochemical activity, has significant implica-
tions for the UvrD-unwinding mechanism.
Assembly State of UvrD and UvrDD40C—The assembly state
(i.e. monomer, dimer, oligomer) of UvrD and UvrDD40C was
examined by analytical sedimentation equilibrium ultracen-
trifugation experiments (Fig. 2). The predicted molecular
masses, based on amino acid composition, are 82,151 Da for
UvrD and 77,850 Da for UvrDD40C. The average apparent
molecular mass, as revealed by equilibrium sedimentation, was
119.8 kDa for UvrD and 61.1 kDa for UvrDD40C. These appar-
ent molecular masses represent the average mass of species
present in the ultracentrifuge cell.
For wild-type helicase II, molecular mass was consistent
with a mixture of monomers and dimers. Several models were
fit to the equilibrium centrifugation data for UvrD and
UvrDD40C, including single ideal species, monomer 7 dimer,
monomer 7 trimer, monomer 7 tetramer, and non-ideality.
All of the data analyzed for UvrD were most consistent with the
monomer 7 dimer model described by Equation 2 (Fig. 2A,
solid line). Using this equation, the Kd for dimerization was
calculated to be 3.4 mM.
The average apparent molecular mass determined for
UvrDD40C was consistent with the monomeric molecular
mass. In addition, the apparent molecular mass of UvrDD40C
did not increase with an increase in protein concentration, even
2 L. E. Mechanic and S. W. Matson, unpublished data.
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at protein concentrations more than 2-fold greater than the
highest wild-type protein concentration. The lower than ex-
pected apparent molecular mass for UvrDD40C may be due to
the presence of 20% glycerol in the ultracentrifuge cell. It has
been reported that glycerol can affect the observed molecular
mass in equilibrium sedimentation experiments (36). If this is
the case, then the molecular mass reported for UvrD may be an
underestimate. All of the data for UvrDD40C were most con-
sistent with a model for a single-ideal species (Fig. 2B, dashed
line) with a monomeric molecular mass. A dimerization con-
stant for UvrDD40C could not be determined since the mono-
mer7 dimer model failed to converge to the data (Fig. 2B, solid
line). Thus, UvrDD40C fails to dimerize, consistent with the
results obtained from the yeast two-hybrid system.
To determine whether ligands could enhance the dimeriza-
tion of either protein, sedimentation velocity experiments were
performed in the presence and absence of a poorly hydrolyzable
ATP analog and ssDNA. It has been shown previously, using
other techniques, that dimerization of Rep occurs only on
ssDNA and is therefore ligand-induced (13, 15). It is important
to note that the sedimentation coefficient (s20,w) reflects both
the size and shape of the protein. The s20,w of a dimer should
increase by a factor of 1.5 over that for a monomer (39, 40).
Such an increase has been demonstrated previously for the
gene 41 helicase from phage T4 which dimerizes in the pres-
ence of GTP (11). Sedimentation velocity experiments with
UvrD were possible only in the presence of DNA and AMP-
PNP, due to the limited solubility of wild-type helicase II in the
absence of DNA (Table I). However, it was possible to measure
sedimentation velocity for UvrDD40C in the absence of ligands,
in the presence of nucleotide, and in the presence of DNA plus
nucleotide.
The UvrDD40C sedimentation coefficient in the absence of
ligands was 7.0 6 0.3 (Table I). Scans of the ultracentrifuge cell
during the course of the velocity sedimentation experiments
failed to show any biphasic character suggestive of multiple
species in the cell (i.e. populations of monomers and dimers).
Moreover, multiple species models did not fit the data as well
as the modified Fujita-MacCoshman function for a single spe-
cies. The sedimentation coefficient for UvrDD40C decreased in
the presence of an ATP analog (AMP-PNP) relative to that of
the protein alone and decreased further in the presence of
(dT)16 and AMP-PNP. The decrease in s20,w indicates that the
protein is undergoing a conformational change in the presence
of these ligands. The change in s20,w is not consistent with the
notion that the protein dimerizes in the presence of either one
FIG. 1. UvrD interacts with itself in the yeast two-hybrid sys-
tem. A, HF7c cells containing pGAD424 and pGBT9 with or without the
uvrD gene were grown at 30 °C on complete synthetic media lacking
tryptophan, leucine, and histidine and supplemented with 1 mM 3-ami-
no-1,2,4-triazole. Each quadrant contains cells streaked from a single
transformant that was colony-purified. Labels represent fusion proteins
present in the HF7c cells in the order, DNA binding domain fusion/
transcriptional activation domain fusion. A 2 represents the absence of
uvrD from the fusion construct. B, b-galactosidase activity was meas-
ured in yeast SFY526 cells using o-nitrophenyl b-D-galactopyranoside
as described under “Experimental Procedures.” Truncations of the uvrD
gene were constructed in pGAD424 and were tested for an interaction
in the presence of pGBT9-UvrD. A 1 indicates the presence of an
interaction and a 2 indicates the absence of an interaction. All assays
scored as interactions displayed at least a 40-fold increase in b-galac-
tosidase activity (Miller units) compared with a control in the absence
of a UvrD-activation domain fusion. All results represent the average of
2 or 3 separate experiments using independent transformants.
FIG. 2. Sedimentation equilibrium of UvrD and UvrDD40C. The
association state of UvrD and UvrDD40C was analyzed using analytical
ultracentrifugation. Data shown are a subset of all the data acquired at
three different speeds and protein concentrations for both UvrD and
UvrDD40C as described under “Experimental Procedures.” A, UvrD
samples (2.1 mM) were sedimented at 7,500 rpm (E) and 10,000 rpm (l).
The equation for the monomer 7 dimer equilibrium (2) was fit to the
data (solid line). B, UvrDD40C (5.0 mM) samples were sedimented at
7200 (E) and 12,960 rpm (l). The monomer 7 dimer model, using
Equation 2 (solid line) and the equation for a single ideal species, C(r)
5 d 1 C1,0e (s1j) (dashed line) (28), were fit to the data. Protein
absorbance was measured at 280 nm. Data analysis was performed
using NONLIN (28) as detailed under “Experimental Procedures.”
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or both ligands. Even if the assumption that this protein be-
haves as an anhydrous sphere is incorrect, it is unlikely that
the sedimentation coefficient would decrease upon dimeriza-
tion because s20,w is directly proportional to the molecular mass
of the species and inversely proportional to shape factors. The
sedimentation coefficient for wild-type helicase II in the pres-
ence of AMP-PNP and DNA was 5.1 6 0.1. This was strikingly
similar to the result obtained for UvrDD40C under the same
conditions. It is known from the equilibrium sedimentation
experiments described above that UvrDD40C behaves as a
monomer. Thus, this result suggests that the monomeric form
of wild-type UvrD may be stabilized in the presence of an ATP
analog and ssDNA.
UvrDD40C Elutes as a Monomer on a Gel Filtration Col-
umn—To confirm the UvrDD40C oligomerization defect re-
vealed in the yeast two-hybrid and ultracentrifugation experi-
ments, high pressure liquid chromatography gel filtration was
used to determine the apparent molecular mass of UvrD and
UvrDD40C in the presence and absence of ligands. In the
absence of ligands, UvrD eluted as a single peak with an
apparent molecular mass between that expected for a mono-
meric (82 kDa) and dimeric (164 kDa) protein (Fig. 3A and
Table II). Under very similar solution conditions (specifically
the presence of Mg21) Runyon et al. (19) observed the same
result, and it is consistent with a rapid equilibrium between
monomeric and oligomeric species. In contrast to UvrD,
UvrDD40C eluted as a single peak consistent with the pre-
dicted molecular mass for the monomeric protein (78 kDa). It
should also be noted that the UvrD elution peak was consis-
tently broader than that of UvrDD40C and exhibited a shallow
trailing slope, suggesting that UvrD existed as a heterogeneous
population of molecules (Fig. 3, A and B). The symmetry of the
UvrDD40C peak is consistent with a homogeneous population
of molecules.
In the presence of ATP, UvrD eluted with a lower apparent
molecular mass than in the absence of ATP (Fig. 3B and Table
II) but still appeared to exist in a rapid equilibrium between
monomeric and dimeric species. The apparent molecular mass
of UvrDD40C did not change significantly in the presence of
ATP, again suggesting that this protein exists in solution as a
monomer. The shift in the UvrD elution peak is consistent with
the notion that ATP binding stabilizes the monomeric form of
UvrD. The shift to a lower apparent molecular mass is not
consistent with an ATP-induced dimerization of UvrD.
To investigate the possibility that DNA binding affects the
oligomeric state of UvrD or restores the ability of UvrDD40C to
dimerize, gel filtration was performed using a pre-formed en-
zyme-ssDNA complex. In the presence of ATP and oligonucleo-
tide (dT)16, the apparent molecular masses of UvrD and
UvrDD40C increased by approximately the same amount com-
pared with experiments in which only ATP was present (Table
II, 119 versus 98 kDa for UvrD and 91 versus 73 kDa for
TABLE I
Sedimentation coefficients
Velocity sedimentation experiments were performed as described
under “Experimental Procedures.” UvrD and UvrDD40C were approx-
imately 7.5 mM. Data from experiments containing protein alone and
those with protein and AMP-PNP (0.2 mM) were collected at 290 nm.
Data from experiments containing the 2-AP-modified (dT)16 oligonu-
cleotide were collected at 315 nm. DNA to protein molar ratios were
1.25:1. s* values for the protein alone and protein plus AMP-PNP were
obtained using Svedberg (30). Experiments containing DNA were ana-
lyzed using the dCdT program, and sw values were obtained based on
the assumption of interacting species (32). s* and sw (uncorrected sed-
imentation coefficients) were normalized to standard conditions (s20,w)
as described under “Experimental Procedures.”
Enzyme Ligand s20,w (S)
UvrDD40C 7.0 6 0.3
AMP-PNP 5.7 6 0.3
AMP-PNP, (dT)16 4.8 6 0.1
UvrD AMP-PNP, (dT)16 5.1 6 0.1
FIG. 3. UvrD and UvrDD40C elute from a Superose 12 column
at different positions. 25 mg of UvrD or UvrDD40C were applied to a
Superose 12 column as described under “Experimental Procedures” in
the absence (A) and presence (B) of 500 mM ATP. The retention times of
the samples were defined as the points of maximum absorbance at 280
nm on the elution traces and are indicated by the vertical dashed lines.
Independent traces of UvrD and UvrDD40C were superimposed on one
another. Arrows indicate the elution peaks of the five proteins used to
generate the standard curve for apparent molecular mass calculations.
B, the absorbance at 280 nm was initially normalized to zero to elimi-
nate the contribution of ATP to the signal. This resulted in the lower
apparent absorbances of UvrD and UvrDD40C compared with those in
A.
TABLE II





UvrD 55.7, 55.8 109




UvrD (1ATP)d 56.6, 56.8 98
UvrDD40C (1ATP)d 59.3, 59.4 73
UvrD (1ATP, 1(dT)16)
e 54.9, 55.0 119
UvrDD40C (1ATP, 1(dT)16)
e 57.4, 57.4 91
(dT)16
c 68.6 26
a 25 mg of each protein were loaded in a volume of 50 ml (final
concentration 5 6 mM).
b Retention times of duplicate trials are shown to demonstrate repro-
ducibility of results.
c Results obtained with UvrD and UvrDD40C represent the average
of two identical experiments. Results obtained with UvrD point mu-
tants represent a single trial. Apparent molecular mass was deter-
mined using a standard curve as described under “Experimental Pro-
cedures.”
d 0.5 mM ATP was included in the sample and in the column buffer.
e 32P-Labeled (dT)16 was included in the sample at a concentration of
11.2 mM.
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UvrDD40C). Since (dT)16 eluted from the column with an ap-
parent molecular mass of 26 kDa (Table II), the size of the
increase in each case was consistent with that expected from
binding of (dT)16 to the enzyme and was not large enough to
suggest a stimulation of oligomerization. It is important to note
that the apparent molecular mass of the UvrDD40C-(dT)16
complex was still significantly lower than that of the UvrD-
(dT)16 complex. Thus, the oligomerization defect exhibited by
UvrDD40C in the absence of DNA was not corrected by the
presence of ssDNA. We confirmed that the protein-(dT)16 com-
plex was reasonably stable during the gel filtration experi-
ments by using radiolabeled (dT)16 and comparing the elution
positions of the DNA and protein (data not shown). Although
the protein-ssDNA complexes were clearly in a rapid equilib-
rium between bound and unbound states relative to the time
course of the experiments, the concentration of (dT)16 in the
protein peak indicated that greater than 60% of the helicase II
was bound to DNA.
Genetic and Biochemical Characterization of UvrDD40C—
Since UvrDD40C fails to oligomerize, and oligomerization has
been suggested to be essential for helicase activity (5), it was of
interest to evaluate the activity of UvrDD40C in genetic and
biochemical assays. The ability of UvrDD40C to complement
the loss of UvrD in methyl-directed mismatch repair and exci-
sion repair was examined using a strain lacking the uvrD gene.
JH137DuvrD was transformed with pET9d-UvrDD40C and
pET9d-UvrD. Uninduced expression of UvrD and UvrDD40C
from these constructs in JH137DuvrD was detectable by West-
ern blot and was similar to chromosomal levels of expression of
the wild-type gene in JH137 (data not shown). To assess func-
tion in methyl-directed mismatch repair, the spontaneous mu-
tant frequency was measured by quantifying the number of
spontaneously arising rifampicin-resistant colonies. Previous
studies have shown that wild-type UvrD, expressed from a
plasmid, fully complements the loss of helicase II (23, 37, 41).
The relative mutability of JH137DuvrD was 240-fold greater
than the parental strain, JH137 (data not shown). JH137
DuvrD containing pET9d-UvrD or pET9d-UvrDD40C exhibited
relative mutant frequencies of 1.01 and 0.92, respectively, dem-
onstrating complete complementation of the uvrD deletion (Ta-
ble III). The UV sensitivity of these strains was also measured
at increasing doses of UV irradiation to evaluate nucleotide
excision repair function. The UV sensitivity of JH137DuvrD/
pET9d-UvrDD40C was comparable to that of JH137 and
JH137DuvrD/pET9d-UvrD (data not shown). Thus, UvrDD40C
is fully functional in both mismatch and excision repair.
UvrDD40C was also characterized in biochemical assays.
UvrD and UvrDD40C were purified to apparent homogeneity
(data not shown), and UvrDD40C was assayed for ssDNA-
stimulated ATPase activity and DNA helicase activity. The
ssDNA binding ability of UvrDD40C was investigated previ-
ously and was found to be similar to that of the wild-type
protein.2 The turnover rates for ssDNA-stimulated ATP hy-
drolysis (kcat) for both proteins were not significantly different
(147 versus 157 s21). In addition, both UvrDD40C and UvrD
appeared to interact with nucleotide with the same affinity as
evidenced by the nearly identical Km values for ATP (62 versus
50 mM). The helicase reaction catalyzed by each protein was
measured using a 92-bp partial duplex DNA substrate (Fig. 4).
UvrD and UvrDD40C unwound the partial duplex substrate
with equivalent efficiency. Similar results were obtained with a
238-bp blunt duplex substrate (data not shown). The rates of
unwinding of the 92-bp partial duplex substrate by UvrD and
UvrDD40C during the course of a 10-min reaction were similar.
In fact, the rate of unwinding catalyzed by UvrDD40C was
reproducibly slightly greater than that of UvrD (data not
shown). Thus, UvrDD40C possesses wild-type ATPase and he-
licase activities in vitro, consistent with its ability to function
in vivo.
The ssDNA-stimulated ATPase Activity of UvrD Is Independ-
ent of Protein Concentration—Since UvrDD40C fails to oli-
gomerize and exhibits wild-type biochemical and genetic activ-
ity, we suggest that the protein is functional as a monomer.
This prompted further investigations to determine if wild-type
UvrD was also functional as a monomer. Toward this end,
several biochemical properties of UvrD were evaluated.
The kcat for ssDNA-stimulated ATP hydrolysis catalyzed by
UvrD was previously reported to increase by a factor of 2.5 as
a function of enzyme concentration between 2 and 10 nM (19).
Thus, the rate of hydrolysis of UvrD was non-linearly depend-
ent on enzyme concentration in this range. This result was
interpreted as evidence for the dimerization of UvrD causing a
stimulation of its ATPase activity and as support for an un-
winding model involving an active dimeric enzyme. Because
the stimulation of ATPase activity was small (only 2.5-fold) and
UvrD still demonstrated significant activity at concentrations
below the inflection point, we attempted to reproduce this
result. Under our reaction conditions, the ssDNA-stimulated
ATPase activity of UvrD was independent of protein concen-
tration between 1 and 64 nM. In other words, the rate of ATP
hydrolysis was linearly dependent on UvrD concentration (Fig.
5) and provided no evidence for a change in assembly state.
Since typical biochemical DNA unwinding assays of UvrD are
performed within this range of protein concentrations, these
results must be representative of the active species. Unless
UvrD has a dimerization constant below 1 nM under these
conditions (which we have demonstrated is not the case), these
results strongly argue that UvrD monomers are an active form
of the enzyme, at least as an ATPase.
ATPase- and Helicase-deficient UvrD Mutants Do Not Inhibit
the ssDNA-stimulated ATPase or ATP-dependent Helicase Ac-
tivities of Wild-type UvrD—As a further test of our conclusion
that UvrD monomers are active as DNA helicases, the effect of
adding non-functional UvrD mutants to ATPase and helicase
FIG. 4. Helicase activity of UvrD and UvrDD40C. The unwinding
activity of UvrD (l) and UvrDD40C (E) was measured using a 92-bp
partial duplex substrate as described under “Experimental Proce-
dures.” The fraction of unwound substrate molecules was calculated for
each protein concentration as outlined (24). Data represent the average
of at least 3 independent experiments, and error bars are standard
deviations about the mean. Continuous lines connecting data points
were drawn using a cubic spline algorithm (SigmaPlot).
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reactions was evaluated. If a dimeric enzyme were required for
biochemical activity, then the presence of an excess molar
concentration of an inactive mutant should inhibit the reaction
catalyzed by the wild-type enzyme, assuming random associa-
tion of wild-type and mutant subunits. Such a result has been
observed previously with the E. coli Rep helicase (42) and the
bacteriophage T7 gene 4 helicase-primase (43, 44) which are
known to function as a dimer and hexamer, respectively. The
ssDNA-stimulated ATPase reaction catalyzed by UvrD was
measured in the presence of three UvrD point mutants that
were severely compromised for ATPase activity (Fig. 6A). Each
mutant contained a single amino acid substitution of a highly
conserved residue within one of the helicase motifs and had
been characterized previously (21, 23, 24). Mutant enzymes
were present at a 30-fold molar excess over wild-type UvrD,
and oligonucleotide (dT)16 was used as the ssDNA effector at a
molar excess over enzyme to ensure that ssDNA availability
was not limiting. Wild-type and mutant enzymes were co-
incubated under conditions that favor monomeric species prior
to initiation of the reactions to ensure random mixing of protein
molecules. At this molar excess of mutant protein, essentially
all wild-type molecules should be complexed as a heterodimer
with an inactive mutant if dimers are formed. The results
clearly demonstrate that the presence of a molar excess of
mutant enzyme did not significantly inhibit the ssDNA-stimu-
lated ATPase activity of wild-type UvrD. Although the kcat for
ATP hydrolysis appeared to decrease slightly in the presence of
each mutant (112 versus 79–89 s21), a requirement for active
dimers should have resulted in more dramatic inhibition (to
mutant kcat levels 0.058–0.283 s
21). Co-incubation of mutant
and wild-type enzymes for a much longer period prior to the
reaction did not alter the results (data not shown). In addition,
co-incubation of the two proteins in the presence of Mg21 or
Mg21-ATP or inclusion of mutant enzyme at a 300-fold molar
excess did not yield different results (data not shown).
It is possible to imagine a mechanism for dimer-mediated
helicase unwinding in which the two subunits of the dimer act
independently as ATPases. In such a scenario, inhibition of the
ATPase reaction by inactive mutant enzymes would not be
observed. However, it is considerably more difficult to imagine
a dimer-mediated unwinding model in which mutants did not
inhibit unwinding of duplex DNA requiring multiple turnovers
of the enzyme.
Helicase inhibition assays similar to the ATPase inhibition
assays described above were performed, in which the unwind-
ing activity of UvrD was measured in the presence of the same
FIG. 5. The UvrD-catalyzed ssDNA-stimulated ATPase reac-
tion is linearly dependent on enzyme concentration between 1
and 64 nM. ATPase assays were performed at 37 °C as described under
“Experimental Procedures” using oligonucleotide (dT)16 as the ssDNA
effector. The straight line is a linear regression (SigmaPlot) and corre-
sponds to a kcat of 78 s
21. The data for each enzyme concentration were
determined in individual experiments involving 5 time points, and each
data point represents the average of 2 separate trials.
FIG. 6. Inactive UvrD point mutants do not inhibit the ATPase
or helicase activities of wild-type UvrD. A, ATPase assays were
performed as described under “Experimental Procedures.” When pres-
ent, the concentration of UvrD was 4 nM, and the concentration of each
mutant was 125 nM. Data represent the average of at least 3 independ-
ent trials. When both wild-type and mutant enzymes were present, the
contribution of mutant enzymes to kcat was subtracted from the data. B,
helicase assays were performed as described under “Experimental Pro-
cedures.” When present, the concentration of UvrD was 1 nM, and the
concentration of mutant enzymes was 3 nM. The concentration of 20-bp
partial duplex DNA substrate molecules in all reactions was 5 nM. The
data for wild-type or mutant enzymes alone are an average of at least
3 independent trials. The data for reactions containing both wild-type
and mutant enzymes are an average of at least 5 independent trials.
The horizontal dashed line represents the expected level of unwinding
in reactions containing wild-type and mutant enzymes if a dimer were
the active species and assuming random association of protein mole-
cules. In both panels error bars are standard deviations.
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catalytically compromised mutant enzymes. Mutant enzymes
were present at a 3-fold molar excess over wild-type enzyme
(higher concentrations of the mutant proteins could not be
achieved for technical reasons), and a 20-bp partial duplex
DNA substrate was present at a molar concentration slightly
greater than the total concentration of enzyme monomers. The
step size for UvrD-catalyzed DNA unwinding was recently
reported to be 4–5 nucleotides (20). Therefore, displacement of
the 20-mer oligonucleotide should require 4–5 cycles of catal-
ysis. Again, the wild-type and mutant proteins were co-incu-
bated prior to initiation of the reaction (see “Experimental
Procedures”). A large molar excess of unlabeled 20-mer was
included upon initiation of the reaction with ATP to prevent
reannealing of displaced radiolabeled 20-mer molecules. This
rendered the reactions pseudo-single turnover. Under these
conditions, UvrD alone unwound 25% of the DNA substrate
(Fig. 6B). Unwinding by the three mutant enzymes alone was
negligible, as expected. Assuming random association of sub-
units, a 3:1 ratio of mutant to wild-type enzyme should result
in 25% activity compared with wild-type UvrD alone if an
active dimeric species were required for unwinding. Fig. 6B
demonstrates that this result was not obtained. These results,
coupled with the ATPase results, indicate that UvrD is func-
tional as a monomer and that oligomerization is not obligatory
for catalytic competency.
Although the mutant enzymes could be defective at dimer-
ization, it is unlikely that three separate point mutations in
different regions of the protein would all impact oligomeriza-
tion. However, to ensure that this was not the case, the appar-
ent molecular mass of the three mutant enzymes was deter-
mined by gel filtration and compared with UvrD (see Table II).
All four proteins exhibited similar apparent molecular masses
that were suggestive of a rapid equilibrium between mono-
meric and oligomeric species. In addition, the UvrD-K35M
protein was analyzed by sedimentation equilibrium ultracen-
trifugation, and the data were described by a monomer 7
dimer equilibrium with a dissociation constant similar to that
of UvrD (data not shown). The average apparent molecular
mass for UvrD-K35M was 116.7 kDa, similar to the wild-type
value. These results suggest that the oligomerization proper-
ties of the mutant enzymes were not compromised.
Non-functional Mutant UvrD Alleles Are Recessive to Wild-
type UvrD in Two DNA Repair Pathways—Data obtained from
previous genetic studies are also consistent with the conclusion
that UvrD is active as a monomer. Site-directed mutagenesis of
highly conserved residues in the consensus helicase motifs
resulted in the generation of point mutants that failed to func-
tion in vivo (21, 23, 24, 37, 45). Although previously reported
for several UvrD mutants, little attention was directed to the
recessive nature of all non-functional alleles in a wild-type
uvrD background. Table III shows previously published genetic
complementation data for four uvrD alleles that lack in vivo
mismatch repair function. When expressed in JH137DuvrD,
none of the mutant alleles substituted for wild-type UvrD (first
data column). Furthermore, in JH137, containing a wild-type
uvrD allele on the chromosome, none of the mutant alleles
affected the spontaneous mutant frequency (second column)
indicating that the mutant alleles were recessive to the wild-
type gene. It should be noted that mutant alleles were ex-
pressed at near chromosomal levels as evidenced by Western
blots (data not shown). The lack of a dominant negative phe-
notype is consistent with a model in which UvrD acts as a
monomer since the inactive mutant enzymes did not interfere
with function of the wild-type enzyme. Similar results were
obtained with various other uvrD alleles examined for mis-
match and/or excision repair function (data not shown). Efforts
to overexpress mutant uvrD alleles in a wild-type background
to observe a dominant negative phenotype were not interpret-
able since overexpression of wild-type UvrD resulted in UV
sensitivity and increased mutation rate.
DISCUSSION
The precise mechanism by which a DNA helicase catalyzes
the unwinding of duplex DNA is not known, although it is clear
that this process requires energy supplied by the hydrolysis of
NTPs. Thus, there must be a coupling of ATP hydrolysis with
disruption of the hydrogen bonds between the two strands of
duplex DNA. It has been postulated that helicase-catalyzed
unwinding requires an oligomeric enzyme (at least a dimer),
and reasonably detailed models have been proposed for un-
winding by a dimeric (15) or hexameric helicase (5, 46). A
fundamental component of these models is the notion that each
protomer in the oligomer contributes a DNA-binding site. Thus,
an oligomer has at least two DNA-binding sites allowing the
enzyme to remain in contact with the DNA, through one of
these binding sites, during multiple cycles of unwinding and
translocation through a duplex region of DNA.
The dimeric Rep protein and the hexameric T7 gene 4 heli-
case have been most rigorously studied and currently provide
paradigms for an understanding of helicase-catalyzed unwind-
ing. The T7 gene 4 helicase is thought to encircle the ssDNA
molecule along which it translocates and utilizes alternate
protomers of the hexamer to unwind the duplex region (46).
The dimeric Rep protein has been proposed to unwind duplex
DNA via a mechanism in which the two protomers alternate
binding to ssDNA and dsDNA at the ssDNA/dsDNA junction
during cycles of nucleotide binding, hydrolysis, and product
release (15). This mechanism is termed the “rolling mecha-
nism” since one can envision the helicase subunits rolling
through the duplex region.
Since Rep protein and UvrD share approximately 40% amino
acid identity and several biochemical properties, it has been
suggested that the two proteins are likely to unwind duplex
DNA by the same mechanism involving a dimeric helicase (20).
However, we have presented compelling evidence in this report
to indicate that the monomeric form of UvrD is an active
helicase both in vitro and in vivo. Therefore, an unwinding
mechanism involving a monomeric helicase must be consid-
ered, and it is likely that Rep and UvrD unwind DNA by
substantially different mechanisms.
The assembly state of active UvrD has been a matter of
speculation for some time. Previous studies using gel filtration
and protein-protein cross-linking (19) provided evidence to sug-
gest that UvrD forms dimers and higher order oligomers. Pro-
tein-protein cross-linking can detect very weak or transient
interactions. However, interactions observed with this tech-
TABLE III
Genetic complementation experiments
An expression plasmid encoding the indicated allele was transformed
into either JH137DuvrD or JH137. Spontaneous mutant frequency was
measured as described (37). Expression of mutant alleles was confirmed
by Western blot and was approximately equal to chromosomal expres-
sion of the wild-type allele. Relative mutant frequencies with respect to
the parental strain, JH137, were obtained by dividing the mutant
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nique need to be confirmed with other methods because they
may not reflect true association (47). Therefore, we used other
reliable physical techniques to investigate the assembly state
of UvrD. Gel filtration studies clearly suggest the existence of
a population of UvrD monomers and oligomers (presumably
dimers) in equilibrium. In addition, analytical equilibrium ul-
tracentrifugation studies using purified UvrD indicate that the
enzyme can form dimers with a Kd for dimerization of 3.4 mM.
This is the first report of a dissociation constant for the dimer-
ization of UvrD. Interestingly, ATP and/or ssDNA ligands did
not enhance the dimerization of UvrD as has been reported for
other helicases such as Rep (13, 14) and the phage T7 gene 4
protein (8). In fact, sedimentation velocity ultracentrifugation
and gel filtration chromatography experiments suggest that
ATP and ssDNA stabilize the monomeric form of UvrD. It is
important to note that the dimerization constant reported here
is fairly high in relation to the concentration of UvrD present in
the cell (0.3–0.8 mM (21)). Therefore, oligomerization of the
protein may not be relevant under normal growth conditions
(see below), although the possibility of non-ideal behavior in
vivo resulting in a lower apparent dimerization constant can-
not be rigorously excluded.
By using the yeast two-hybrid system we identified a UvrD
mutant lacking the C-terminal 40 amino acids that potentially
possessed a dimerization defect. Equilibrium ultracentrifuga-
tion and gel filtration chromatography confirmed that purified
UvrDD40C was not able to dimerize in vitro in the absence of
ligands. Similar to results obtained with wild-type UvrD, ATP,
and/or ssDNA did not induce dimerization of UvrDD40C. How-
ever, this protein maintained full biochemical activity as a
helicase and a ssDNA-stimulated ATPase and was fully func-
tional in vivo in DNA repair. The simplest interpretation of
these results is that UvrDD40C is an active monomeric
helicase.
The biophysical data clearly indicate that UvrDD40C exists
as a monomer in solution and, whereas UvrD is capable of
dimerization, it too exists as a monomer at protein concentra-
tions typically used for in vitro enzymatic assays. Additional
biochemical experiments using wild-type UvrD yielded results
that were also consistent with a monomeric helicase. The
ATPase and helicase activities of UvrD were not significantly
inhibited by the presence of a molar excess of ATPase and
helicase-deficient UvrD point mutants. Inhibition in these ex-
periments would be expected if dimers or oligomers were re-
quired for activity but not if monomers were sufficient for
activity. A previous study (21) reported inhibition of UvrD-
catalyzed unwinding by the UvrD-K35M mutant. This result
was likely due to limiting concentrations of DNA which re-
sulted in competition between wild-type and mutant monomers
for the substrate molecules. Based on all the biophysical and
biochemical data obtained in this study, we conclude that
dimerization of UvrD (or UvrDD40C) is not required for activity
as a ssDNA-stimulated ATPase nor is it required for helicase
activity.
We also note that genetic studies shown here, and reported
previously, are consistent with the notion that UvrD is active
as a monomer. UvrDD40C was fully functional in vivo, and
since the helicase activity of UvrD has been shown to be re-
quired for activity in mismatch and excision repair (21, 23, 24,
37), monomeric UvrDD40C (and, by inference, monomeric
UvrD) must be active as a helicase in both repair pathways. In
addition, a variety of uvrD alleles that failed to function in
these DNA repair pathways was recessive to wild-type uvrD
(21, 23, 45). The recessive nature of the mutant uvrD alleles
examined here suggests that the UvrD helicase activity re-
quired in UV excision and methyl-directed mismatch repair
does not involve oligomerization. In similar studies, a domi-
nant phenotype has been demonstrated for mutants of the
herpes simplex virus type 1 UL9 helicase (48), a protein that is
believed to function as a dimer (49, 50).
Taken together, the studies reported here strongly support
the conclusion that the active species of UvrD is a monomer
and that oligomerization of the protein is either irrelevant or
important only when the cellular concentration of UvrD is very
high (e.g. after SOS induction as discussed below). In fact, these
results provide the first direct evidence for a helicase that is
able to catalyze duplex nucleic acid unwinding as a monomer.
Previous studies using the HCV RNA helicase (51) and purified
RecB protein (52) have suggested these enzymes may be func-
tional monomers. It is important to note that the three helicase
crystal structures available are all monomers (53–55), al-
though it was argued that the dimeric form of Rep helicase may
be resistant to attempts at crystallization. Thus, it is likely that
several monomeric helicases exist. Therefore, a mechanism for
unwinding by a monomeric helicase must be considered.
Unfortunately, there is not enough mechanistic data avail-
able for helicase II to provide a detailed description of its
unwinding mechanism. One possible model is based on multi-
ple DNA-binding sites within the monomeric enzyme. This
would allow for continuous translocation of the helicase along
ssDNA and through dsDNA since at least one binding site
would be in contact with the DNA lattice at all times. Proces-
sive translocation, made possible by the multiple DNA-binding
sites, would likely be driven by conformational changes in the
enzyme triggered by nucleotide binding and hydrolysis that are
coupled to the actual unwinding event. There is evidence both
for helicase II translocation along ssDNA (56, 57) and confor-
mational changes associated with ligand binding (24, 58), lend-
ing support to this type of model. In addition, based on the
crystal structure of the Rep helicase complexed to ssDNA (54)
and site-directed mutagenesis studies of helicase II (24, 41),2 it
is likely that ssDNA is contacted by several distinct regions of
the enzyme. Such a model would be fundamentally similar to
the “inchworm” model originally proposed for E. coli Rep heli-
case (59, 60). Although less likely, an entirely different type of
model is possible for a monomeric helicase in which the heli-
case does not actively translocate along the DNA molecule. In
this model, the enzyme preferentially binds to a ssDNA/dsDNA
junction. After each unwinding event, a new junction is made
available for another helicase molecule to bind.
If we assume that UvrD translocates along ssDNA during an
unwinding reaction, as previous studies have indicated (56, 57)
and as suggested by the pseudo-single turnover helicase assays
performed here, then a version of the inchworm model for DNA
unwinding may be a suitable working model for helicase II-
catalyzed unwinding (Fig. 7). This model assumes at least two
non-equivalent DNA-binding sites on the monomeric protein.
The leading site (L) must have an affinity for duplex DNA and
may also bind ssDNA, whereas the trailing DNA-binding site
(T) need only have an affinity for ssDNA. The binding of ATP,
its subsequent hydrolysis, and product release would cause the
protein to cycle between two or more conformational states as
the protein “inches” along the DNA. A cycle of unwinding
begins with the enzyme in an “extended” conformation (Fig.
7A), in which the T site is bound to ssDNA and the L site is
extended forward in the vicinity of the ssDNA/dsDNA junction.
Binding of ATP to the enzyme triggers tight binding of the L
site to the ssDNA/dsDNA junction and induces a conforma-
tional change in the protein to a more compact state in which
the T site is shifted forward along the DNA lattice with respect
to the L site (Fig. 7B). This results in a transient high affinity
DNA binding state. In support of this idea sedimentation ve-
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locity ultracentrifugation experiments reported here have
shown that the ATP-bound conformational state is more com-
pact than the ATP-free state. In addition, a previous report
demonstrated that the ATP-bound state possesses a higher
affinity for DNA (24). Upon ATP hydrolysis, a distinct number
of base pairs (4–5 according to a recent report (20)) are dis-
rupted at the ssDNA/dsDNA junction, and product release is
associated with a return of the enzyme to its original confor-
mation by extension of the L site forward with respect to the T
site (Fig. 7C). At this point, the L site is in close proximity to
the new ssDNA/dsDNA junction, and the cycle is repeated to
catalyze further unwinding.
Precedent for the large conformational changes required to
fulfill such a model can be seen in the crystal structure of Rep
helicase bound to ssDNA (54). The crystal structure of Rep
revealed two distinct conformations differing by a 130° rotation
of one of the four subdomains with respect to the other three
subdomains. The two conformations were referred to as “open”
and “closed” because in one orientation the rotating subdomain
was extended away from the protein core and in the other
orientation it was folded over the bound ssDNA molecule. Since
UvrD and Rep share nearly 40% identity at the amino acid
sequence level, it is likely that the two proteins adopt similar
structures. Indeed, Rep and the PcrA protein from Bacillus
stearothermophilus also share 40% identity and have crystal
structures that are nearly identical (53, 54). Thus, UvrD may
be capable of adopting open and closed conformations, similar
to those adopted by Rep, that are relevant to its duplex DNA
unwinding mechanism. However, it must be noted that the
unwinding mechanisms used by UvrD and Rep are likely to be
distinctly different.
What is the biological significance, if any, of the dimerization
of helicase II? Genetic studies have indicated that a monomer-
catalyzed unwinding reaction is sufficient for the role of UvrD
in both excision repair and methyl-directed mismatch repair.
However, UvrD does oligomerize at high concentration, and
helicase II has been observed to coat ssDNA generated during
an unwinding reaction in electron microscopic studies (61, 62).
We consider two possibilities for the role of UvrD dimerization
although there may be others. First, oligomerization of UvrD
may play a role in the SOS response in E. coli. Under normal
growth conditions the majority of UvrD present in the cell,
assuming a Kd for dimerization of about 3 mM, is likely to be in
a monomeric form. However, SOS induction of the uvrD gene
can raise the UvrD concentration by as much as 6-fold (63).
Under these conditions a significant fraction of the UvrD could
be present as dimers. Thus, a role for dimeric UvrD in the cell
after SOS induction is possible. The role for UvrD as part of the
SOS response is not understood at present but may have some-
thing to do with recombinational repair of DNA damage. Sec-
ond, UvrD is known, from a variety of genetic studies, to have
a role in recombination. This role has not been well character-
ized at the molecular level. In fact, contradictory effects on
recombination have been observed in genetic analyses of uvrD
mutant alleles and in biochemical assays with wild-type UvrD.
In some cases uvrD mutations correlated with a hyper-recom-
bination phenotype, whereas in other cases recombination was
decreased (64–67). Purified helicase II inhibited strand ex-
change catalyzed by RecA protein under certain conditions but
stimulated the same reaction under other conditions (68).
These contradictory results may suggest that UvrD has more
than a single role in recombination. Perhaps UvrD is required
to coat ssDNA to accomplish one of its roles in recombination.
Significant structural similarity with RecA protein, which self-
associates and coats ssDNA to form nucleoprotein filaments,
has been observed in the crystal structures of both Rep and
PcrA which, for reasons stated above, are likely to be accurate
reflections of the structure of UvrD. We have not, as yet,
evaluated the well characterized uvrD alleles with regard to
their effect on recombination in the cell. Additional experi-
ments will be required to appreciate the role of UvrD oligomer-
ization in the cellular function of helicase II.
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